Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice
NCT ID: NCT05981911
Last Updated: 2026-01-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2000 participants
OBSERVATIONAL
2023-12-14
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice
NCT03967158
Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
NCT01186133
XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice
NCT02042300
DESyne in Routine Clinical Practice
NCT02039713
Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent
NCT05044273
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
XIENCE Skypoint™ stent
Patients receiving Xience-Skypoint™ stents
XIENCE Skypoint™ stent
Percutaneous coronary intervention with Xience-Skypoint™ stent
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
XIENCE Skypoint™ stent
Percutaneous coronary intervention with Xience-Skypoint™ stent
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients receiving Xience-Skypoint™ stents.
3. The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.
Exclusion Criteria
2. Terminal illness with life expectancy \<1 year
3. Patients with cardiogenic shock
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seung-Jung Park
OTHER
CardioVascular Research Foundation, Korea
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seung-Jung Park
Professor, Department of Cardiology, University of Ulsan College of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Asan Medical Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AMCCV2023-04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.